High Prevalence of Long COVID in Common Variable Immunodeficiency: An Italian Multicentric Study

A Villa, C Milito, CM Deiana, RF Gambier… - Journal of Clinical …, 2024 - Springer
The long-term effects of SARS-CoV-2 infection represent a relevant global health problem.
Long COVID (LC) is defined as a complex of signs and symptoms developed during or after …

[HTML][HTML] Surprising protective mechanisms against severe forms of COVID-19 infection among Common Variable Immunodeficiency Patients-one center experience.

C Petricau, I Nedelea, D Deleanu - 2020 - europepmc.org
In this report we aimed to present the nonthreatening experience of patients diagnosed with
Common variable immunodeficiency (CVID) included in the National Rare Disease Program …

Low morbidity in Danish patients with common variable immunodeficiency disorder infected with severe acute respiratory syndrome coronavirus 2

CH Drabe, ABE Hansen, LD Rasmussen… - Infectious …, 2021 - Taylor & Francis
Background Manifestations and outcomes of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection are not well documented in patients with common variable …

Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort study

TL Katzenstein, LD Rasmussen, CH Drabe… - Frontiers in …, 2022 - frontiersin.org
The risk of severe adult respiratory coronavirus-2 (SARS-CoV-2) infection and the course of
the infection among individuals with common variable immunodeficiency (CVID) relative to …

COVID‐19 infection in CVID patients: What we know so far

N Weifenbach, A Jung, S Lötters - Immunity, Inflammation and …, 2021 - Wiley Online Library
Introduction In patients with common variable immunodeficiency (CVID), immunological
response is compromised. Knowledge about COVID‐19 in CVID patients is sparse. We …

The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review

A Al-Hakim, M Kacar, S Savic - Journal of Clinical Medicine, 2024 - mdpi.com
Common Variable Immunodeficiency (CVID) is a heterogeneous primary immunodeficiency
disorder characterised by impaired antibody production, leading to recurrent infections and …

[PDF][PDF] Common variable immunodeficiency: predisposing or protective factor for severe complications of COVID-19?

T Ferenc, T Vilibić-Čavlek - Acta clinica Croatica, 2022 - hrcak.srce.hr
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The usual presentation of the …

COVID-19 in CVID: a case series of 17 patients

JR Greenmyer, AY Joshi - Journal of clinical immunology, 2022 - Springer
Common variable immunodeficiency (CVID), caused by failure of B-cell differentiation with
subsequent defective immunoglobulin production, presents heterogeneously as recurrent …

Mild to moderate clinical course of COVID-19 infection in patients with common variable immune deficiency

S Lesichkova, S Mihailova, E Naumova… - … European Journal of …, 2022 - termedia.pl
The association of immunocompromised patients and severity of COVID-19 infection is not
well established. According to the Centers for Disease Control and Prevention (CDC) …

Clinical outcomes of COVID-19 in common variable immunodeficiency patients

D Nye, L Kaminsky, T Al-Shaikhly - Journal of Allergy and Clinical …, 2022 - jacionline.org
Methods We queried the TriNetX COVID-19 Research Network (n= 84,961,620) for patients
with CVID on immunoglobulin replacement diagnosed with COVID-19 (01/20/2020 …